Recent advances in the diagnosis and classification of endocervical glandular lesions

Current Diagnostic Pathology

Volumn 10, Issue 5, 2004, Pages 404-412

  Ioffe, O B ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Endocervical adenocarcinoma; Endocervical glandular lesions

Indexed keywords

ANDROGEN RECEPTOR; CALRETININ; CARCINOEMBRYONIC ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; ESTROGEN RECEPTOR; KI 67 ANTIGEN; MUCIN; PROGESTERONE RECEPTOR; PROTEIN P53; VIMENTIN;

ABDOMINAL HYSTERECTOMY; APOPTOSIS; ARGENTAFFIN CELL; CANCER INVASION; CANCER SURVIVAL; CELL STRUCTURE; CERVICAL MESONEPHRIC ADENOCARCINOMA; CERVICAL MICROINVASIVE ADENOCARCINOMA; CURETTAGE; DEEP NABOTHIAN CYST; DIFFUSE LAMINAR ENDOCERVICAL GLANDULAR HYPERPLASIA; ENDOMETRIUM CARCINOMA; GOBLET CELL; HUMAN; IN SITU HYBRIDIZATION; LOBULAR ENDOCERVICAL GLANDULAR HYPERPLASIA; LYMPH NODE METASTASIS; MESONEPHRIC REMNANT HYPERPLASIA; METAPLASIA; MICROCYSTIC ENDOCERVICAL ADENOCARCINOMA; MITOSIS; ORAL CONTRACEPTION; PANETH CELL; PAPANICOLAOU TEST; PATHOGENESIS; PROGNOSIS; QUANTITATIVE ANALYSIS; REVIEW; SCORING SYSTEM; SIGNET RING CARCINOMA; STROMA CELL; SURVIVAL RATE; SURVIVAL TIME; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CONIZATION; UTERINE CERVIX DISEASE; UTERINE CERVIX DYSPLASIA; UTERINE CERVIX EPITHELIUM; WART VIRUS;

EID: 3342976478     PISSN: 09686053     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cdip.2004.04.008     Document Type: Article

References (86)

1. Schwartz S.M., Weiss N.S. Increased incidence of adenocarcinoma of the cervix in young women in the United States. Am J Epidemiol. 124:1986;1045-1047
2. Lee K.R., Flynn C.E. Early invasive adenocarcinoma of the cervix. Cancer. 89:2000;1048-1055
3. Tase T., Okagaki T., Clark B.A., et al. Human papillomavirus DNA in adenocarcinoma in situ, microinvasive adenocarcinoma of the uterine cervix, and coexisting cervical squamous intraepithelial neoplasia. Int J Gynecol Pathol. 8:1989;8-17
4. Boon M.E., Baak J.P., Kurver P.J., et al. Adenocarcinoma in situ of the cervix. an underdiagnosed lesion Cancer. 48:1981;768-773
5. Kashimura M., Shinohara M., Oikawa K., et al. An adenocarcinoma in situ of the uterine cervix that developed into invasive adenocarcinoma after 5 years. Gynecol Oncol. 36:1990;128-133
6. Jaworski R.C., Pacey N.F., Greenberg M.L., Osborn R.A. The histologic diagnosis of adenocarcinoma in situ and related lesions of the cervix uteri. Adenocarcinoma in situ. Cancer. 61:1988;1171-1181
7. Brown L.J., Wells M. Cervical glandular atypia associated with squamous intraepithelial neoplasia. a premalignant lesion? J Clin Pathol. 39:1986;22-28
8. Gloor E., Hurlimann J. Cervical intraepithelial glandular neoplasia (adenocarcinoma in situ and glandular dysplasia). A correlative study of 23 cases with histologic grading, histochemical analysis of mucins, and immunohistochemical determination of the affinity for four lectins. Cancer. 58:1986;1272-1280
9. Biscotti C.V., Hart W.R. Apoptotic bodies. a consistent morphologic feature of endocervical adenocarcinoma in situ Am J Surg Pathol. 22:1998;434-439
10. Ali-Fehmi R., Qureshi F., Lawrence W.D., Jacques S.M. Apoptosis, proliferation, and expression of p53 and bcl-2 in endocervical glandular intraepithelial lesions and invasive endocervical adenocarcinoma. Int J Gynecol Pathol. 23:2004;1-6
11. Zaino R.J. Symposium Part I. adenocarcinoma in situ, glandular dysplasia, and early invasive adenocarcinoma of the uterine cervix Int J Gynecol Pathol. 21:2002;314-326
12. Lacey J.V. Jr., Brinton L.A., Abbas F.M., et al. Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas. Cancer Epidemiol Biomarkers Prev. 8:1999;1079-1085
13. Hopkins M.P. Adenocarcinoma in situ of the cervix - the margins must be clear. Gynecol Oncol. 79:2000;4-5
14. Denehy T.R., Gregori C.A., Breen J.L. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix. Obstet Gynecol. 90:1997;1-6
15. Goldstein N.S., Mani A. The status and distance of cone biopsy margins as a predictor of excision adequacy for endocervical adenocarcinoma in situ. Am J Clin Pathol. 109:1998;727-732
16. Im D.D., Duska L.R., Rosenshein N.B. Adequacy of conization margins in adenocarcinoma in situ of the cervix as a predictor of residual disease. Gynecol Oncol. 59:1995;179-182
17. Bertrand M., Lickrish G.M., Colgan T.J. The anatomic distribution of cervical adenocarcinoma in situ. implications for treatment Am J Obstet Gynecol. 157:1987;21-25
18. Ostor A.G., Duncan A., Quinn M., Rome R. Adenocarcinoma in situ of the uterine cervix. an experience with 100 cases Gynecol Oncol. 79:2000;207-210
19. Jaworski R.C. Endocervical glandular dysplasia, adenocarcinoma in situ, and early invasive (microinvasive) adenocarcinoma of the uterine cervix. Semin Diagn Pathol. 7:1990;190-204
20. Farnsworth A., Laverty C., Stoler M.H. Human papillomavirus messenger RNA expression in adenocarcinoma in situ of the uterine cervix. Int J Gynecol Pathol. 8:1989;321-330
21. Moritani S., Ioffe O.B., Sagae S., et al. Mitotic activity and apoptosis in endocervical glandular lesions. Int J Gynecol Pathol. 21:2002;125-133
22. Casper G.R., Ostor A.G., Quinn M.A. A clinicopathologic study of glandular dysplasia of the cervix. Gynecol Oncol. 64:1997;166-170
23. Higgins G.D., Phillips G.E., Smith L.A., et al. High prevalence of human papillomavirus transcripts in all grades of cervical intraepithelial glandular neoplasia. Cancer. 70:1992;136-146
24. Leary J., Jaworski R., Houghton R. In-situ hybridization using biotinylated DNA probes to human papillomavirus in adenocarcinoma-in-situ and endocervical glandular dysplasia of the uterine cervix. Pathology. 23:1991;85-89
25. Qizilbash A.H. In-situ and microinvasive adenocarcinoma of the uterine cervix. A clinical, cytologic and histologic study of 14 cases. Am J Clin Pathol. 64:1975;155-170
26. Nielsen A.L. Human papillomavirus type 16/18 in uterine cervical adenocarcinoma in situ and adenocarcinoma. A study by in situ hybridization with biotinylated DNA probes. Cancer. 65:1990;2588-2593
27. Schlesinger C., Silverberg S.G. Endocervical adenocarcinoma in situ of tubal type and its relation to atypical tubal metaplasia. Int J Gynecol Pathol. 18:1999;1-4
28. Lee K.R., Sun D., Crum C.P. Endocervical intraepithelial glandular atypia (dysplasia). a histopathologic, human papillomavirus, and MIB-1 analysis of 25 cases Hum Pathol. 31:2000;656-664
29. Zaino R.J. Glandular lesions of the uterine cervix. Mod Pathol. 13:2000;261-274
30. Ioffe O.B., Sagae S., Moritani S., et al. Proposal of a new scoring scheme for the diagnosis of noninvasive endocervical glandular lesions. Am J Surg Pathol. 27:2003;452-460
31. Hurlimann J., Gloor E. Adenocarcinoma in situ and invasive adenocarcinoma of the uterine cervix. An immunohistologic study with antibodies specific for several epithelial markers. Cancer. 54:1984;103-109
32. Cina S.J., Richardson M.S., Austin R.M., Kurman R.J. Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix. Mod Pathol. 10:1997;176-180
33. van Hoeven K.H., Ramondetta L., Kovatich A.J., et al. Quantitative image analysis of MIB-1 reactivity in inflammatory, hyperplastic, and neoplastic endocervical lesions. Int J Gynecol Pathol. 16:1997;15-21
34. Pirog E.C., Isacson C., Szabolcs M.J., et al. Proliferative activity of benign and neoplastic endocervical epithelium and correlation with HPV DNA detection. Int J Gynecol Pathol. 21:2002;22-26
35. Riethdorf L., Riethdorf S., Lee K.R., et al. Human papillomaviruses, expression of p16, and early endocervical glandular neoplasia. Hum Pathol. 33:2002;899-904
36. Liao S.Y., Brewer C., Zavada J., et al. Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinomas. Am J Pathol. 145:1994;598-609
37. Negri G., Egarter-Vigl E., Kasal A., et al. p16INK4a is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors. an immunohistochemical study with immunocytochemical correlations Am J Surg Pathol. 27:2003;187-193
38. Cameron R.I., Maxwell P., Jenkins D., McCluggage W.G. Immunohistochemical staining with MIB1, bcl2 and p16 assists in the distinction of cervical glandular intraepithelial neoplasia from tubo-endometrial metaplasia, endometriosis and microglandular hyperplasia. Histopathology. 41:2002;313-321
39. Bonds L., Baker P., Gup C., Shroyer K.R. Immunohistochemical localization of cdc6 in squamous and glandular neoplasia of the uterine cervix. Arch Pathol Lab Med. 126:2002;1164-1168
40. Teshima S., Shimosato Y., Kishi K., et al. Early stage adenocarcinoma of the uterine cervix. Histopathologic analysis with consideration of histogenesis. Cancer. 56:1985;167-172
41. Ostor A.G. Early invasive adenocarcinoma of the uterine cervix. Int J Gynecol Pathol. 19:2000;29-38
42. Ostor A., Rome R., Quinn M. Microinvasive adenocarcinoma of the cervix. a clinicopathologic study of 77 women Obstet Gynecol. 89:1997;88-93
43. Berek J.S., Hacker N.F., Fu Y.S., et al. Adenocarcinoma of the uterine cervix. histologic variables associated with lymph node metastasis and survival Obstet Gynecol. 65:1985;46-52
44. Yeh I.T., LiVolsi V.A., Noumoff J.S. Endocervical carcinoma. Pathol Res Pract. 187:1991;129-144
45. Fu Y.S., Berek J.S., Hilborne L.H. Diagnostic problems of in situ and invasive adenocarcinomas of the uterine cervix. Appl Pathol. 5:1987;47-56
46. Kaku T., Kamura T., Sakai K., et al. Early adenocarcinoma of the uterine cervix. Gynecol Oncol. 65:1997;281-285
47. Webb J.C., Key C.R., Qualls C.R., Smith H.O. Population-based study of microinvasive adenocarcinoma of the uterine cervix. Obstet Gynecol. 97:2001;701-706
48. Schorge J.O., Lee K.R., Flynn C.E., et al. Stage IA1 cervical adenocarcinoma. definition and treatment Obstet Gynecol. 93:1999;219-222
49. Schorge J.O., Lee K.R., Sheets E.E. Prospective management of stage IA(1) cervical adenocarcinoma by conization alone to preserve fertility. a preliminary report Gynecol Oncol. 78:2000;217-220
50. Vizcaino A.P., Moreno V., Bosch F.X., et al. International trends in the incidence of cervical cancer. I. Adenocarcinoma and adenosquamous cell carcinomas Int J Cancer. 75:1998;536-545
51. Kjaer S.K., Brinton L.A. Adenocarcinomas of the uterine cervix. the epidemiology of an increasing problem Epidemiol Rev. 15:1993;486-498
52. Thomas D.B., Ray R.M. Oral contraceptives and invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix. The World Health Organization collaborative study of Neoplasia and steroid contraceptives. Am J Epidemiol. 144:1996;281-289
53. Duggan M.A., McGregor S.E., Benoit J.L., et al. The human papillomavirus status of invasive cervical adenocarcinoma. a clinicopathological and outcome analysis Hum Pathol. 26:1995;319-325
54. Cuzick J., Terry G., Ho L., et al. Association between high-risk HPV types, HLA DRB1* and DQB1* alleles and cervical cancer in British women. Br J Cancer. 82:2000;1348-1352
55. Lacey J.V. Jr., Brinton L.A., Barnes W.A., et al. Use of hormone replacement therapy and adenocarcinomas and squamous cell carcinomas of the uterine cervix. Gynecol Oncol. 77:2000;149-154
56. Young R.H., Scully R.E. Villoglandular papillary adenocarcinoma of the uterine cervix. A clinicopathologic analysis of 13 cases. Cancer. 63:1989;1773-1779
57. Jones M.W., Silverberg S.G., Kurman R.J. Well-differentiated villoglandular adenocarcinoma of the uterine cervix. a clinicopathological study of 24 cases Int J Gynecol Pathol. 12:1993;1-7
58. Kaku T., Kamura T., Shigematsu T., et al. Adenocarcinoma of the uterine cervix with predominantly villoglandular papillary growth pattern. Gynecol Oncol. 64:1997;147-152
59. Castrillon D.H., Lee K.R., Nucci M.R. Distinction between endometrial and endocervical adenocarcinoma. an immunohistochemical study Int J Gynecol Pathol. 21:2002;4-10
60. Alkushi A., Irving J., Hsu F., et al. Immunoprofile of cervical and endometrial adenocarcinomas using a tissue microarray. Virchows Arch. 442:2003;271-277
61. McCluggage W.G., Sumathi V.P., McBride H.A., Patterson A. A panel of immunohistochemical stains, including carcinoembryonic antigen, vimentin, and estrogen receptor, aids the distinction between primary endometrial and endocervical adenocarcinomas. Int J Gynecol Pathol. 21:2002;11-15
62. Kamoi S., AlJuboury M.I., Akin M.R., Silverberg S.G. Immunohistochemical staining in the distinction between primary endometrial and endocervical adenocarcinomas. another viewpoint Int J Gynecol Pathol. 21:2002;217-223
63. Staebler A., Sherman M.E., Zaino R.J., Ronnett B.M. Hormone receptor immunohistochemistry and human papillomavirus in situ hybridization are useful for distinguishing endocervical and endometrial adenocarcinomas. Am J Surg Pathol. 26:2002;998-1006
64. Plunkett M., Brestovac B., Thompson J., et al. The value of HPV DNA typing in the distinction between adenocarcinoma of endocervical and endometrial origin. Pathology. 35:2003;397-401
65. McCluggage W.G., Jenkins D. p16 Immunoreactivity may assist in the distinction between endometrial and endocervical adenocarcinoma. Int J Gynecol Pathol. 22:2003;231-235
66. Kaku T., Enjoji M. Extremely well-differentiated adenocarcinoma ('adenoma malignum') of the cervix. Int J Gynecol Pathol. 2:1983;28-41
67. Kaminski P.F., Norris H.J. Minimal deviation carcinoma (adenoma malignum) of the cervix. Int J Gynecol Pathol. 2:1983;141-152
68. Michael H., Grawe L., Kraus F.T. Minimal deviation endocervical adenocarcinoma. clinical and histologic features, immunohistochemical staining for carcinoembryonic antigen, and differentiation from confusing benign lesions Int J Gynecol Pathol. 3:1984;261-276
69. Young R.H., Scully R.E. Minimal-deviation endometrioid adenocarcinoma of the uterine cervix. A report of five cases of a distinctive neoplasm that may be misinterpreted as benign. Am J Surg Pathol. 17:1993;660-665
70. Gilks C.B., Young R.H., Aguirre P., et al. Adenoma malignum (minimal deviation adenocarcinoma) of the uterine cervix. A clinicopathological and immunohistochemical analysis of 26 cases. Am J Surg Pathol. 13:1989;717-729
71. Hirai Y., Takeshima N., Haga A., et al. A clinicocytopathologic study of adenoma malignum of the uterine cervix. Gynecol Oncol. 70:1998;219-223
72. Fujiwaki R., Takahashi K., Kitao M. Adenoma malignum of the uterine cervix associated with Peutz-Jeghers syndrome. Int J Gynaecol Obstet. 53:1996;171-172
73. Mikami Y., Hata S., Melamed J., et al. Lobular endocervical glandular hyperplasia is a metaplastic process with a pyloric gland phenotype. Histopathology. 39:2001;364-372
74. Ferry J.A., Scully R.E. Mesonephric remnants, hyperplasia, and neoplasia in the uterine cervix. A study of 49 cases. Am J Surg Pathol. 14:1990;1100-1111
75. Clement P.B., Young R.H., Keh P., et al. Malignant mesonephric neoplasms of the uterine cervix. A report of eight cases, including four with a malignant spindle cell component. Am J Surg Pathol. 19:1995;1158-1171
76. Silver S.A., Devouassoux-Shisheboran M., Mezzetti T.P., Tavassoli F.A. Mesonephric adenocarcinomas of the uterine cervix. a study of 11 cases with immunohistochemical findings Am J Surg Pathol. 25:2001;379-387
77. Kondi-Pafitis A., Kairi E., Kontogianni K.I., et al. Immunopathological study of mesonephric lesions of cervix uteri and vagina. Eur J Gynaecol Oncol. 24:2003;154-156
78. Ordi J., Romagosa C., Tavassoli F.A., et al. CD10 expression in epithelial tissues and tumors of the gynecologic tract. a useful marker in the diagnosis of mesonephric, trophoblastic, and clear cell tumors Am J Surg Pathol. 27:2003;178-186
79. Pirog E.C., Kleter B., Olgac S., et al. Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma. Am J Pathol. 157:2000;1055-1062
80. Tambouret R., Bell D.A., Young R.H. Microcystic endocervical adenocarcinomas. a report of eight cases Am J Surg Pathol. 24:2000;369-374
81. Nucci M.R., Clement P.B., Young R.H. Lobular endocervical glandular hyperplasia, not otherwise specified. a clinicopathologic analysis of thirteen cases of a distinctive pseudoneoplastic lesion and comparison with fourteen cases of adenoma malignum Am J Surg Pathol. 23:1999;886-891
82. Jones M.A., Young R.H., Scully R.E. Diffuse laminar endocervical glandular hyperplasia. A benign lesion often confused with adenoma malignum (minimal deviation adenocarcinoma). Am J Surg Pathol. 15:1991;1123-1129
83. Seidman J.D., Tavassoli F.A. Mesonephric hyperplasia of the uterine cervix. a clinicopathologic study of 51 cases Int J Gynecol Pathol. 14:1995;293-299
84. Clement P.B., Young R.H. Deep nabothian cysts of the uterine cervix. A possible source of confusion with minimal-deviation adenocarcinoma (adenoma malignum). Int J Gynecol Pathol. 8:1989;340-348
85. Segal G.H., Hart W.R. Cystic endocervical tunnel clusters. A clinicopathologic study of 29 cases of so-called adenomatous hyperplasia. Am J Surg Pathol. 14:1990;895-903
86. Jones M.A., Young R.H. Endocervical type A (noncystic) tunnel clusters with cytologic atypia. A report of 14 cases. Am J Surg Pathol. 20:1996;1312-1318